Evaluating novel engagement mechanisms, yields and acceptability of tuberculosis screening at retail pharmacies in Ho Chi Minh City, Viet Nam.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
09
2021
accepted:
28
08
2022
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Pharmacies represent a key health system entry point for people with TB in Viet Nam, but high fragmentation hinders their broader engagement. Professional networking apps may be able to facilitate pharmacy engagement for systematic TB screening and referral. Between September and December 2019, we piloted the use of a social networking app, SwipeRx, to recruit pharmacists for a TB referral scheme across four districts of Ho Chi Minh City, Viet Nam. We measured chest X-ray (CXR) referrals and TB detection yields at participating pharmacies and fielded 100 acceptability surveys, divided into pharmacists who did and did not make a CXR referral. We then fitted mixed-effect odds proportional models to explore acceptability factors that were associated with making a CXR referral. 1,816 push notifications were sent to pharmacists via the SwipeRx app and 78 indicated their interest in participating; however, only one was within the pilot's intervention area. Additional in-person outreach resulted in the recruitment of 146 pharmacists, with 54 (37.0%) making at least one CXR referral. A total of 182 pharmacy customers were referred, resulting in a total of 64 (35.2%) CXR screens and seven people being diagnosed with TB. Compared to pharmacists who did not make any CXR referrals, pharmacists making at least one CXR referral understood the pilot's objectives more clearly (aOR = 2.6, 95% CI: 1.2-5.8) and they believed that TB screening increased customer trust (aOR = 2.7, 95% CI: 1.2-5.8), benefited their business (aOR = 2.8, 95% CI: 1.3-6.2) and constituted a competitive advantage (aOR = 4.4, 95% CI: 1.9-9.9). They were also more confident in using mHealth apps (aOR = 3.1, 95 CI%: 1.4-6.8). Pharmacies can play an important role in early and increased TB case finding. It is critical to highlight the value proposition of TB referral schemes to their business during recruitment. Digital networking platforms, such as SwipeRx, can facilitate referrals for TB screening by pharmacists, but their ability to identify and recruit pharmacists requires optimization, particularly when targeting specific segments of a nation-wide digital network.
Identifiants
pubmed: 36962503
doi: 10.1371/journal.pgph.0000257
pii: PGPH-D-21-00625
pmc: PMC10021543
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000257Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright: © 2022 TRAN et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Int J Tuberc Lung Dis. 2003 Dec;7(12):1147-53
pubmed: 14677889
Int J Tuberc Lung Dis. 2012 Dec;16(12):1625-9
pubmed: 23131260
Trop Med Infect Dis. 2020 Sep 14;5(3):
pubmed: 32937757
BMC Health Serv Res. 2017 Jan 26;17(1):88
pubmed: 28126032
Public Health Rep. 2006 May-Jun;121(3):228-34
pubmed: 16640143
Trop Med Infect Dis. 2020 Feb 14;5(1):
pubmed: 32075073
J Infect Dis. 2017 Nov 6;216(suppl_7):S686-S695
pubmed: 29117351
West J Med. 1985 Mar;142(3):409-12
pubmed: 3993022
Indian J Med Sci. 2008 Mar;62(3):118-23
pubmed: 18376086
Int J Tuberc Lung Dis. 2012 Aug;16(8):1086-91
pubmed: 22687275
Health Policy Plan. 2001 Mar;16(1):68-73
pubmed: 11238433
BMJ Glob Health. 2019 May 13;4(3):e001417
pubmed: 31179037
Indian J Tuberc. 2020 Apr;67(2):189-201
pubmed: 32553311
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):983-990
pubmed: 30092862
Implement Sci. 2021 May 19;16(1):54
pubmed: 34011353
Am J Trop Med Hyg. 2020 Jul;103(1):221-230
pubmed: 32372744
Am J Pharm Educ. 2016 Mar 25;80(2):18
pubmed: 27073271
Online J Public Health Inform. 2018 Sep 21;10(2):e215
pubmed: 30349633
Health Informatics J. 2016 Jun;22(2):99-112
pubmed: 25038200
PLoS One. 2020 Nov 23;15(11):e0241437
pubmed: 33226990
BMC Infect Dis. 2020 Aug 5;20(1):579
pubmed: 32758160
Int J Tuberc Lung Dis. 2000 Nov;4(11):1052-9
pubmed: 11092718
PLoS One. 2021 May 7;16(5):e0250644
pubmed: 33961645
Trop Med Infect Dis. 2020 Nov 30;5(4):
pubmed: 33265972
J Clin Epidemiol. 2002 Nov;55(11):1148-55
pubmed: 12507680
Trop Med Int Health. 2011 Oct;16(10):1260-7
pubmed: 21692960
Health Policy Plan. 2001 Mar;16(1):47-54
pubmed: 11238430
Am J Health Syst Pharm. 2008 Mar 1;65(5):462-7
pubmed: 18281740
Infect Dis Poverty. 2020 Dec 9;9(1):166
pubmed: 33292638
J Pharm Policy Pract. 2017 Jan 18;10:6
pubmed: 28116106
PLoS Med. 2019 Sep 3;16(9):e1002890
pubmed: 31479454
Int J Tuberc Lung Dis. 2002 Feb;6(2):171-3
pubmed: 11931419
Health Policy. 1998 Aug;45(2):81-97
pubmed: 10186226
Drug Alcohol Rev. 2008 Jul;27(4):420-8
pubmed: 18584393
Int J Health Policy Manag. 2017 Jan 22;6(6):305-308
pubmed: 28812822
J Clin Tuberc Other Mycobact Dis. 2019 Dec 02;18:100135
pubmed: 31872080
Int J Tuberc Lung Dis. 1999 Nov;3(11):992-1000
pubmed: 10587321
Trop Med Int Health. 2014 Sep;19(9):1076-81
pubmed: 24995611
Lancet Reg Health West Pac. 2020 Nov 28;5:100059
pubmed: 34327397
Int J Tuberc Lung Dis. 2007 Aug;11(8):893-7
pubmed: 17705956
BMC Public Health. 2020 Jun 15;20(1):934
pubmed: 32539700